BioAtla Statistics
Share Statistics
BioAtla has 58.42M
shares outstanding. The number of shares has increased by 20.59%
in one year.
| Shares Outstanding | 58.42M |
| Shares Change (YoY) | 20.59% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 49.68% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 35,827 |
| FTD / Avg. Volume | 5.73% |
Short Selling Information
The latest short interest is 4.3M, so 7.36% of the outstanding
shares have been sold short.
| Short Interest | 4.3M |
| Short % of Shares Out | 7.36% |
| Short % of Float | 8.25% |
| Short Ratio (days to cover) | 7.52 |
Valuation Ratios
The PE ratio is -0.41 and the forward
PE ratio is -0.37.
BioAtla's PEG ratio is
0.01.
| PE Ratio | -0.41 |
| Forward PE | -0.37 |
| PS Ratio | 2.61 |
| Forward PS | 0.1 |
| PB Ratio | 2.01 |
| P/FCF Ratio | -0.4 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for BioAtla.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.52,
with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.52 |
| Quick Ratio | 3.52 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $180,327.87 |
| Profits Per Employee | $-1,143,868.85 |
| Employee Count | 61 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -77.19% in the
last 52 weeks. The beta is 1, so BioAtla's
price volatility has been higher than the market average.
| Beta | 1 |
| 52-Week Price Change | -77.19% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 1.07 |
| Relative Strength Index (RSI) | 45.89 |
| Average Volume (20 Days) | 625,715 |
Income Statement
In the last 12 months, BioAtla had revenue of 11M
and earned -69.78M
in profits. Earnings per share was -1.44.
| Revenue | 11M |
| Gross Profit | 10.07M |
| Operating Income | -73.94M |
| Net Income | -69.78M |
| EBITDA | -73.94M |
| EBIT | -73.94M |
| Earnings Per Share (EPS) | -1.44 |
Full Income StatementBalance Sheet
The company has 49.05M in cash and 836K in
debt, giving a net cash position of 48.21M.
| Cash & Cash Equivalents | 49.05M |
| Total Debt | 836K |
| Net Cash | 48.21M |
| Retained Earnings | -486.04M |
| Total Assets | 38.29M |
| Working Capital | 21.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -71.94M
and capital expenditures 0, giving a free cash flow of -71.94M.
| Operating Cash Flow | -71.94M |
| Capital Expenditures | n/a |
| Free Cash Flow | -71.94M |
| FCF Per Share | -1.48 |
Full Cash Flow StatementMargins
Gross margin is 91.59%, with operating and profit margins of -672.21% and -634.33%.
| Gross Margin | 91.59% |
| Operating Margin | -672.21% |
| Pretax Margin | -634.33% |
| Profit Margin | -634.33% |
| EBITDA Margin | -672.21% |
| EBIT Margin | -672.21% |
| FCF Margin | -653.96% |
